Mayo Clinic Physicians are leading sessions at the American Congress of Rehabilitation Medicine in Toronto, Canada. On Friday morning Carmen Terzic, Mayo PM&R Department Chair of moderated a discussion on New Trends in the Care and Rehabilitation of Chronic and Complex Medical Conditions.
The panel included Jeffrey Basford, M.D., PH.D., Andrea Cheville, M.D., and Kristin Zhao, PH.D. Dr. Zhao's portion of the presentation covered the issue of shoulder pain and the rehabilitation challenges for manual wheelchair users and future directions for designing a highly-effective evidence-based shoulder rehabilitation intervention for them.
Isobel Scarisbrick, PH.D., also moderated a separate panel on Emerging Biological Targets for Spinal Cord Repair and Regenerative Rehabilitation. The discussion included Michael G. Fehlings, M.D., Cindi Morshead, M.D., and Andrea Mothe,PH.D. Dr. Scarisbrick detailed promising results of a prospective, multi-center, double blind placebo controlled trial evaluating Riluzole in acute spinal cord injury. She talked about stem cells and how they can help repair the injured spinal cord and the challenges of translating cell therapy and current clinical trials. Pre-clinical studies targeting PARs to limit inflammatory-astrogliosis and promote motor recovery after SCI were also discussed.
Dr. Fehlings' talk focused on the latest advances in translational research for acute spinal cord injury with an emphasis on the multicentre international RISCIS (Riluzole in Acute Spinal Cord Injury) Trial. The trial is a prospective, multicentre, double blind placebo controlled study evaluating the sodium-glutamate antagonist riluzole in acute SCI. Fehlings said his work is based on "exciting preclinical basic science work and a highly promising" Phase I clinical trial in 36 patients.
ACRM 2014 continues through Saturday, October 11. If you're at ACRM, stop by and visit us at booth 2340 and be sure to follow our updates on Twitter @MayoClinicPMR.